These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29723076)

  • 1. Feasibility of Bystander Administration of Public-Access Naloxone for Opioid Overdose.
    Goldberg SA; Dworkis DA; Liao VT; Eyre AJ; Albert J; Fawcett MM; Narovec CM; DiClemente J; Weiner SG
    Prehosp Emerg Care; 2018; 22(6):788-794. PubMed ID: 29723076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of bystander-administered naloxone delivered by drone to opioid overdose victims.
    Ornato JP; You AX; McDiarmid G; Keyser-Marcus L; Surrey A; Humble JR; Dukkipati S; Harkrader L; Davis SR; Moyer J; Tidwell D; Peberdy MA
    Am J Emerg Med; 2020 Sep; 38(9):1787-1791. PubMed ID: 32739849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.
    Jeffery RM; Dickinson L; Ng ND; DeGeorge LM; Nable JV
    J Am Coll Health; 2017 Apr; 65(3):212-216. PubMed ID: 28059635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMS runs for suspected opioid overdose: implications for surveillance and prevention.
    Knowlton A; Weir BW; Hazzard F; Olsen Y; McWilliams J; Fields J; Gaasch W
    Prehosp Emerg Care; 2013; 17(3):317-29. PubMed ID: 23734988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of Bystander-Patient Relationship and Prehospital Care for Opioid Overdose.
    McCann MK; Jusko TA; Jones CMC; Seplaki CL; Cushman JT
    Prehosp Emerg Care; 2021; 25(1):82-90. PubMed ID: 32073921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Effects After Prehospital Administration of Naloxone by Bystanders: A Preliminary Study.
    Du Pont D; Fenderson R; Hunter K; Kuc A; Carroll G
    Prehosp Disaster Med; 2024 Apr; 39(2):212-217. PubMed ID: 38449098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geospatial Clustering of Opioid-Related Emergency Medical Services Runs for Public Deployment of Naloxone.
    Dworkis DA; Weiner SG; Liao VT; Rabickow D; Goldberg SA
    West J Emerg Med; 2018 Jul; 19(4):641-648. PubMed ID: 30013698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency medical services naloxone access: a national systematic legal review.
    Davis CS; Southwell JK; Niehaus VR; Walley AY; Dailey MW
    Acad Emerg Med; 2014 Oct; 21(10):1173-7. PubMed ID: 25308142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England.
    Gulec N; Lahey J; Suozzi JC; Sholl M; MacLean CD; Wolfson DL
    Prehosp Emerg Care; 2018; 22(2):163-169. PubMed ID: 29023172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
    Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
    Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Police Officers Can Safely and Effectively Administer Intranasal Naloxone.
    Fisher R; O'Donnell D; Ray B; Rusyniak D
    Prehosp Emerg Care; 2016; 20(6):675-680. PubMed ID: 27218446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-related incident severity and emergency medical service naloxone administration by sex in Massachusetts, 2013-2019.
    Bettano A; Jones K; Fillo KT; Ficks R; Bernson D
    Subst Abus; 2022; 43(1):479-485. PubMed ID: 34283708
    [No Abstract]   [Full Text] [Related]  

  • 16. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.
    Doe-Simkins M; Walley AY; Epstein A; Moyer P
    Am J Public Health; 2009 May; 99(5):788-91. PubMed ID: 19363214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, Indiana.
    Ray BR; Lowder EM; Kivisto AJ; Phalen P; Gil H
    Addiction; 2018 Dec; 113(12):2271-2279. PubMed ID: 30255531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Simulation for Assessment of Layperson Management of Opioid Overdose With Intranasal Naloxone in a Recently Released Prisoner Cohort.
    Kobayashi L; Green TC; Bowman SE; Ray MC; McKenzie MS; Rich JD
    Simul Healthc; 2017 Feb; 12(1):22-27. PubMed ID: 28146450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone Administration Frequency During Emergency Medical Service Events - United States, 2012-2016.
    Cash RE; Kinsman J; Crowe RP; Rivard MK; Faul M; Panchal AR
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(31):850-853. PubMed ID: 30091966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit.
    Taylor JL; Gott J; Weisenthal K; Colicchio P; Dyer S; Komaromy MS
    Subst Use Addctn J; 2024 Oct; 45(4):771-776. PubMed ID: 38736211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.